Drug Database
Back to search

Netherlands· NL-e80b080d215c

Sucralfaat Aurobindo 1 gram, granulaat in sachets

A sucralfate product containing sucralfaat, registered in Netherlands by Aurobindo Pharma B.V.. The same ATC class is registered in 13 of our 19 countries.

ATC A02BX02

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedSucralfaat Aurobindo 1 gram, granulaa…ATCA02BX02REGISTER NO.NL-e80b080d215cPACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about sucralfaatAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Sucralfate is registered in 13 of 19 countries.

Countries holding a registration under ATC A02BX02 (sucralfate), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 7 of them publish a price we can compare per daily dose
Search sucralfate products by name

Sucralfate · ATC A02BX02

13 / 19 countries

  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of sucralfate costs, country by country.

Normalised to the WHO defined daily dose (4 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Sucralfate · price per daily dose (4 g)

USD · FX 28 Sept 2026

  • IT Italy$0.62
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)
Active substance
SUCRALFAAT
Manufacturer
Aurobindo Pharma B.V.
Country
Netherlands (NL)
ATC code
A02BX02
ATC class
Sucralfate
Defined daily dose
4 g, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    21870=17346

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

504 interactions on record for sucralfate.

Graded by severity as the source publishes them — 5 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check sucralfate against other medicinesHow interaction checks work

Sucralfate · interactions on record

504 records

  • 5 severe
  • 116 moderate
  • 46 minor
  • 337 info

Most severe, free to view

  • ParicalcitolA11CC07severe
  • ParicalcitolH05BX02severe
  • DoxercalciferolH05BX03severe
  • DolutegravirJ05AJ03severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Sucralfate in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All sucralfate products

Authorised across Europe · EMA

The same active substance is authorised in 13 EEA countries. Names it is sold under:

  • Austria · Sucralan, Sucralfat Genericon
  • Germany · Sucrabest
  • Denmark · Antepsin, Peptonorm
  • Finland · Antepsin, Peptonorm
  • France · Keal, Ulcar
  • United Kingdom (Northern Ireland) · Sucralfate Roma Pharmaceuticals
  • Greece · Peptonorm
  • Hungary · Peptonorm
  • Iceland · Antepsin
  • Italy · Antepsin, Sucralfato Doc Generici
  • Norway · Antepsin
  • Portugal · Sucralfato Generis, Sucralfato Jaba
  • Sweden · Andapsin

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ce50055f-6a80-4b77-85c5-cba6424fa197
GET /v1/drugs/ce50055f-6a80-4b77-85c5-cba6424fa197?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Granulaat",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h17346_smpc.pdf",
  "strength": null,
  "atc_label": "Sucralfate",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg21870",
  "excipients": [
    "HYPROLOSE (E 463)",
    "NATRIUMZETMEELGLYCOLAAT"
  ],
  "substances": [
    "SUCRALFAAT"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h21870.pdf",
  "authorised_at": "1997/09/08",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "21870=17346",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about sucralfate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console